Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

SIOG 2017 /
Treating AML in patients over 70

9th - 11th Nov 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 15.11.17
Views: 1138

Dr Martine Extermann - Moffitt Cancer Center, Tampa, USA

Dr Extermann talks to ecancer at SIOG 2017 in Warsaw about the treatment of AML in patients over 70. 

Dr Extermann highlights a meta-analysis covering 68 trials and 13,381 patients.

They compared a variety of treatment techniques and the outcomes of those treatments in various categories of patient health status, using a decision analysis model. 

There seem to be two better results; intensive chemotherapy or hypomethylating agent.

She also discusses when, and if, low dose chemotherapy has a place in geriatric cancer treatment.

This service has been kindly supported by an unrestricted grant from Janssen Oncology.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation